塞力醫療(603716.SH):擬開展不超1.3億元融資租賃及保理業務
格隆匯11月11日丨塞力醫療(603716.SH)公佈,為滿足塞力斯醫療科技集團股份有限公司經營發展需要,拓寬融資渠道,公司擬與上海睿海創世商業保理有限公司(簡稱“海爾金融”)開展融資租賃回租業務和保理融資業務,融資總金額不超過1.3億元,主要用於公司一園四平台(智慧醫療數字化產業園-區域醫學檢驗檢測及病理診斷共享平台、智慧醫院精益化及醫療物質管理平台、醫療廢棄物新型一站式環保處理平台、醫療設備資產全週期管理服務平台)設備採購和補充流動資金,融資期限不超過36個月,自相關融資合同約定的起始日起算。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.